ClinConnect ClinConnect Logo
Search / Trial NCT00749853

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Launched by MEDICAL UNIVERSITY OF VIENNA · Sep 8, 2008

Trial Information

Current as of June 02, 2025

Suspended

Keywords

Ovarian Stimulation Fsh Genotyping Polymorphism

ClinConnect Summary

Women in group A will undergo controlled ovarian stimulation according to the following protocol:

Pituitary down-regulation will be achieved using buserelin (Suprefact®, Hoechst, Frankfurt, Germany) at a fixed daily dose of 200 mg s.c., according to a long agonist protocol, starting on day 2 of the normal menstrual cycle. Treatment with r-hFSH (Gonal-F®, Serono Austria GmbH, Vienna, Austria) will be started in women with serum E2 concentrations \<200 pmol/l and no follicles \>15 mm in diameter or ovarian cysts on ultrasonographic examination. The initial r-hFSH dose will be 250 IU s.c. dai...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18 and 40
  • Informed consent
  • Indication for IVF-ET
  • Exclusion Criteria:
  • Inability to understand written informed consent form
  • Personal history of ovarian hyperstimulation syndrome

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Patients applied

0 patients applied

Trial Officials

Johannes C. Huber, MD, PhD

Study Director

Medical University of Vienna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials